Zyntrigues, Volume 1, Issue 5 - May 2008
Volume 1, Issue 5, - May 2008 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In this Issue
Musingsby Bob Pinkerton, COO How Many Healthcare Experts Does It Take to Build a New H.I.T. Infrastructure? As we look forward to the next series of issues facing your organizations we want to build an inner circle of advisors to help us define desirable functionality for our upcoming releases. We refer to these advisory groups as Zynchros Special Interest Groups (ZSIGS). In the next week you will receive an invitation to participate in the ZSIGs and I hope you will seriously consider participating. The first groups that are forming are:
While the time commitment is minimal (attendance at one online meeting per quarter), the impact upon our product and your environment should prove to be significant. We are planning ZSIG review sessions in person at AMCP 2009 and NCPDP 2009. I hope you’ll consider participating and helping to shape the healthcare management technologies of tomorrow. Please feel free to call and discuss our ZSIGs at 866-ZYNCHROS (866-966-2476) extension 7006. Bob |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| « top» | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Member Formulary Hosting Webcast—Enhance Your Members’ Online Experience with Member Formulary HostingRegister NowThe web is a vital tool for communicating with your members. Please join Zynchros for a demonstration of how we can simplify the creation, presentation and maintenance of pharmacy benefits and fulfillment options for your member website.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| « top» | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special Pricing Promotions – Part D, Commercial & Hosting Options Available!If you have been waiting to sign up for Part D Pro, now is the time to act. New customers can take advantage of free add-on services when you get started by May 30th, 2008. Free services include:
Plus 15% off your renewal on December 31, 2008 An overall savings of at least $11,950.00 For our existing Part D customers looking to add Commercial Plan Pro, order your second module before June 15th, 2008, and receive a free 12-month hosting subscription for one formulary (a savings of $10,000.00). Interested in Member Formulary Hosting? Buy one formulary 12-month hosting subscription and get your second formulary for free (a savings of $10,000.00). Offer expires June 15th, 2008. To take advantage of these promotions, please contact us, today. You can reach us by phone at 866-996-2476, option 1 or you can fill out our online form. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| « top» | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Simplifying Printed Formularies—For You and Your Membersby David Smith, VP Project Management A formulary seems like such a simple thing – it’s just a list of drugs, right? But when it comes to creating a printed version for members (as CMS requires for the Part D program), the devil’s in the details. On the one hand, the printed formulary should be as short and simple as possible, both to ensure clarity for the member and to keep your printing costs low. But on the other hand, the formulary needs to avoid ambiguity that might cause problems for members (and complaints to member services). It may seem obvious to simply list Fluconazole on the formulary at tier 2, but the member may get a nasty surprise to find the injectable version is on the specialty tier instead. Throw in the formatting requirements from CMS and your marketing department, and the formulary isn’t so simple any more. In the latest version of Zynchros.com we’ve created a brand new implementation of the Member Formulary (Word) export for Part D 2009 to automate the listing and formatting of your formulary’s details while giving you more control over how your formulary document is generated. One of the biggest changes is in how we describe drugs on the formulary. Rather than simply listing every drug and every dosage form, we save space by only listing a drug name once if all the dosage forms have the same tier and UM edits. If some formulations are on formulary at a different tier, or have a limitation such as quantity that the other forms don’t, they’ll be listed separately with the appropriate dosage form and/or strength. We also now include the route of administration if needed to distinguish dosage forms, and clearly list injectable products. So most formularies will list each drug only once, but additional entries for specific formulations will automatically be created as necessary, dictated by the details of your formulary. The other major change is in how we describe the utilization management restrictions for each drug. Simple two-letter codes are displayed for the basic UM restrictions:
Also, as required by CMS, similar codes are used to identify:
You can now also provide your own member message for each drug, by using the “Member Comment” field in Zynchros.com. We trust these changes to the Part D 2009 member formulary export represent a significant improvement for your members and a reduction in manual editing for you. As always, if you have any more suggestions for how we can improve Zynchros.com, please let me know at david.smith@zynchros.com. David |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| « top» | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accelerate Your e-Prescribing Initiative with Zynchros and RxHub Joint Webcast
|
Date: |
Tuesday, June 10th |
Time: |
8:30am - 9:30am Pacific Time |
Speakers: |
Marc Lilly, CEO, Zynchros, Inc. & Tom Groom, SVP Business Development, RxHub, LLC |
Tips and Tricks: New Key Fields
By Scott Pillsbury, Director, Customer Service and IT
With the latest update to Zynchros.com (version 2008.05.00) you are now able to view and sort by a few more key fields from the ‘Formulary List’ page. The new fields you’ll notice are:
- Route of Administration: available on all formularies
- PA Group Description: Part D formularies only
- Drug Type: Part D formularies only
- Specialty Pharmacy: Part D formularies only
- HPMS Therapeutic Category: 2009 Part D formularies only
- HPMS Therapeutic Class: 2009 Part D formularies only
By adding these fields, Zynchros provides more flexibility in viewing, sorting, and reviewing your formulary data.
The Route of Administration data field is drawn directly from our drug database. A two letter acronym representing the route of administration is displayed in the column. For your reference, I’ve included a list of those acronyms and their descriptions.
Code |
Route |
Description |
BU |
BUCCAL |
Administered inside the mouth on the mucosa of the cheek |
CO |
COMBINATION |
More than one route, excluding route combinations that only include injectable sites |
DT |
DENTAL |
Application to teeth or gums |
EP |
EPIDURAL* |
Injection upon or outside of the dura mater |
EX |
EXTERNAL |
Applied externally to the skin or hair |
IA |
INTRA-ARTERIAL* |
Injection into an artery or intra-arterial port |
IC |
INTRACAVERNOSAL* |
Injection into the corpora cavernosa |
ID |
INTRADERMAL* |
Injection within the epidermis (skin) |
IJ |
INJECTION |
A set of one or more injectable routes or the route of injection is not specified |
IL |
IMPLANT |
Placing a drug form, drug delivery device, or other device at the desired administration site by insertion into a body tissue or body cavity by surgical or other appropriate insertion procedures |
IM |
INTRAMUSCULAR* |
Injection into a muscle group |
IN |
INHALATION |
Drug administration into the lungs (either during a drawn or forced breath) |
IO |
INTRAOCULAR |
Injection, implantation or surgical irrigation within the eyeball |
IP |
INTRAPERITONEAL |
Administration into the intraperitoneal cavity commonly by injection or instillation into an intraperitoneal catheter port |
IR |
IRRIGATION |
To flush a body cavity or site with a stream of liquid |
IS |
INTRAVESICAL |
Administered into the bladder |
IT |
INTRATHECAL* |
Injection into a subarachnoid or subdural space |
IU |
INTRAUTERINE |
Administered within the uterus |
IV |
INTRAVENOUS* |
Injection directly into a vein or into a venous line port |
IX |
INTRA-ARTICULAR* |
Injection into a joint |
MT |
MOUTH/THROAT |
Applied to a mucus membrane of the oral cavity or throat |
NA |
NASAL |
Administered via the nose |
OP |
OPHTHALMIC |
Administered onto the surface of the eyeball or into the conjuctival sac |
OR |
ORAL |
Taken by mouth |
OT |
OTIC |
Commonly administered into the external ear canal |
PF |
PERFUSION |
Administration (pumping) of a fluid through an organ or tissue |
PL |
INTRAPLEURAL |
Administration into the pleura or pleural cavity. |
RE |
RECTAL |
Administered into the rectum (in the anal canal beyond the anal sphincter) |
SC |
SUBCUTANEOUS* |
Injection through the skin into the loose subcutaneous tissue under the skin |
SL |
SUBLINGUAL |
Administered under the tongue |
TD |
TRANSDERMAL |
Applied topically (e.g., patch or ointment) with absorption through the skin for systemic effect |
TL |
TRANSLINGUAL |
Drug absorption through the tongue into systemic circulation after application on the tongue |
UR |
URETHRAL |
Administered via insertion or instillation into the uretha |
VA |
VAGINAL |
Administered into the vagina |
VI |
IN VITRO |
Not taken internally or applied externally to a patient’s body |
XX |
DOES NOT APPLY |
Use of a route does not apply |
* These Codes are used for drug products limited to this particular route. If more than one route of injection is applicable or if the route of injection is not specified, “IJ” is used.
PA Group Description, Drug Type, and Specialty Pharmacy data are taken directly from the Product Details you have entered for the applicable NDC. If the column is blank, it is because you have not supplied any data for this particular field. *Note: Be careful not to confuse this with the parameters you have set in the “formulary properties” page.
HPMS Therapeutic Category and HPMS Therapeutic Class are also taken directly from the Product Details of the applicable NDC. If you notice that these fields are ‘blank’, it’s because there are multiple valid USP classifications available. In these instances you must edit the product details and ‘manually’ select the classification you would like associated with this NDC. This is the same check that occurs when the ‘Formulary Content Validation’ is run. To easily identify and update NDC’s that are missing their Category/Class just click on the HPMS Category or HPMS Classification column heading. This will sort the columns for you. By sorting the columns in an ascending order the ‘blank’ items will be listed first making editing much easier.
Please feel free to contact me with comments, questions and suggestions for future Tips & Tricks at service@zynchros.com or 866-996-2476 option 2.
Did You Miss a Webcast? Want to Share Information with a Colleague?
You know us – online, on-demand, 24/7 – well, that means you can get the information you need when you want it. Visit our website Resources page and download a webcast, whitepaper or data sheet. You can also read past issues of Zyntrigues, inspect sample reports and request a demonstration.


